⌕
SkinHealth Systems · SKIN · Nasdaq
Tenet 51 · Mixed
Compare
$12.15−2.49%At closeTenet 51 · Mixed
$12.15−0.31 (−2.49%)
At close: Nov 19, 2026, 4:00 PM ET· Nasdaq · USD

SkinHealth Systems (SKIN) Key Ratios

Valuation, quality, health and growth. Every ratio ranked against its sector peers — the number we score — with its own ten-year record shown beside it for context.

Sources Company filings and market prices Filings and pricesRatios computed How we compute thisNot investment advice
64
VALUE
Fairly priced
in line with its peers
49
QUALITY
Decent
mid-pack profitability
21
HEALTH
Fragile
leverage needs watching
70
GROWTH
FCF only
growth rates not measurable; scored on FCF margin alone

A decent business at a fair price: value 64, quality 49, health 21, growth 70, each a percentile within Healthcare.

Values are the trailing twelve months where a company files quarterly statements and the figure passes our check against the filings, with balance-sheet ratios from the most recent quarter; otherwise, or where a sector's figure is still under review, the latest fiscal year. Piotroski and the five-year growth rates are fiscal years. Each row names its period.track = where peers land, worse → better (direction-adjusted: right always means better)▏sector median● you are here▲ where today's value sits in the company's own ten fiscal years (context, not scored)hover any metric for its formula
64th pctilein line with its peers
Earnings yield (EBIT/EV)Trailing twelve months: EBIT (operating income) summed over the four most recent quarters ÷ enterprise value on the current market cap, with debt, preferred stock, minority interest, cash and short-term investments from the most recent quarter's balance sheet (Greenblatt). The vendor's own earnings yield is net income to common ÷ market cap, a different figure.3.4%40th pctileown record too shortEBIT, TTM through Sep 30, 2026 ÷ enterprise value at the close of Nov 19, 2026
P/E—Not meaningful: the company made a loss.
P/B1.386th pctileMarket cap at the close of Nov 19, 2026 ÷ book equity at Sep 30, 2026 (most recent quarter)
P/FCF3.197th pctileown record too shortMarket cap at the close of Nov 19, 2026 ÷ free cash flow, TTM through Sep 30, 2026
EV / EBITDA24.734th pctileown record too shortEnterprise value at the close of Nov 19, 2026 ÷ fiscal 2025 EBITDAFiscal 2025: trailing figures for Healthcare are still under review
21st pctileleverage needs watching
Current ratio2.8942nd pctileMost recent quarter, Sep 30, 2026
Quick ratioMost recent quarter: (Cash, short-term investments and receivables) ÷ current liabilities on the most recent quarter's balance sheet, as the data vendor builds it for that quarter. Its receivables include non-trade receivables, which Tenet's balance sheet shows inside other current assets.1.8737th pctileMost recent quarter, Sep 30, 2026
Net debt / EBITDATotal debt (excluding leases) less cash and short-term investments, over EBITDA (operating income plus depreciation and amortisation) from the filed statements. Total debt is short-term plus long-term borrowings; lease liabilities are not included. Long-term investments are not counted as cash. For some companies they include marketable securities held for more than a year.16.1×3rd pctileown record too shortTenet-derived Total debt (excluding leases) less cash and short-term investments, over EBITDA (operating income plus depreciation and amortisation) from the filed statements. Total debt is short-term plus long-term borrowings; lease liabilities are not included. Long-term investments are not counted as cash. For some companies they include marketable securities held for more than a year. Computed by Tenet from the filed statements (formula house-nde.v1), because the data vendor published no value for this year.Fiscal 2025 (Dec 31, 2025)Fiscal 2025: trailing figures for Healthcare are still under review
Interest coverage—Not meaningful: operating income is zero or negative.
Debt / equity4.362nd pctileMost recent quarter, Sep 30, 2026
49th pctilemid-pack profitability
ROIC2%63rd pctileTTM through Sep 30, 2026
ROE−30%37th pctileTTM through Sep 30, 2026
Gross margin67.2%55th pctileTTM through Sep 30, 2026
Net margin−6.3%36th pctileTTM through Sep 30, 2026
Income quality (CFO/NI)—Not meaningful: the company made a loss.
Piotroski F7 / 988th pctileown record too shortFiscal 2025 (Dec 31, 2025)
Altman Z−0.616th pctileTTM through Sep 30, 2026
70th pctilegrowth rates not measurable; scored on FCF margin alone
Revenue CAGRThe yearly rate that compounds the earliest fiscal year's revenue into the latest one, over the true number of fiscal years between them (up to five). When the earliest year's revenue is zero or negative, the rate starts from the first later year with at least $10M of revenue, provided at least three years remain.—This growth figure starts in a period outside the history your plan includes.
EPS CAGR—This growth figure starts in a period outside the history your plan includes.
FCF margin12.4%71st pctileFiscal 2025 (Dec 31, 2025)Fiscal 2025: trailing figures for Healthcare are still under review
the receipts behind the numbers above
Greenblatt earnings yield3.4%EBIT ÷ EV The vendor's "earningsYield" is NI ÷ market cap, which is not Greenblatt's formula.
ROIC2%NOPAT ÷ invested capital The vendor's simple ROIC, not its tiny-base roic tag; withheld when a negative EBIT flips its sign.
Interest coverage— Guarded, not faked: we have no interest-expense figure on file for this company, so it's excluded from the ranking instead of rendered as garbage.
Percentiles computed nightly against 486 Healthcare peers from our ingested fundamentals DB · raw statements for corrected metrics. Direction-adjusted: for "lower is better" ratios (P/E, D/E…) the percentile is flipped so right always means better. The percentile is the stock's rank among sector peers, the number that is scored. The triangle marks where the current value (the trailing twelve months or the latest fiscal year, as its row names) sits in the company's own ten fiscal-year record, shown for context and never blended into the score. Computed Nov 20, 2026 · Not investment advice.

What is SkinHealth Systems' Piotroski F-Score?

SkinHealth Systems' Piotroski F-Score is 7 of 9 for fiscal 2025.

What is SkinHealth Systems' Altman Z-Score?

SkinHealth Systems' Altman Z-Score is −0.6, TTM through Sep 30, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.